Table 3 Age-standardized Prevalence in 2018
Age, years | Observed migraine patients | Expected migraine patients | Observed prevalence, % | Expected prevalence, % |
|---|---|---|---|---|
18–19 | 128 | 2067.06 | 1.09% | 17.58% |
20–24 | 1438 | 9063.77 | 3.05% | 19.24% |
25–29 | 2949 | 9190.36 | 6.51% | 20.29% |
30–34 | 3950 | 9253.19 | 9.02% | 21.14% |
35–39 | 4140 | 8923.05 | 9.93% | 21.41% |
40–44 | 3369 | 7564.33 | 9.60% | 21.56% |
45–49 | 2779 | 5063.06 | 11.02% | 20.07% |
50–54 | 2555 | 3966.67 | 11.74% | 18.23% |
55–59 | 2503 | 3680.37 | 11.15% | 16.39% |
60–64 | 2272 | 3124.92 | 10.24% | 14.08% |
65–69 | 1638 | 2296.70 | 8.37% | 11.74% |
70–74 | 1072 | 1440.39 | 7.05% | 9.47% |
75–79 | 582 | 830.59 | 5.56% | 7.93% |
80–84 | 333 | 626.92 | 3.66% | 6.89% |
85–89 | 163 | 369.97 | 2.68% | 6.08% |
90–94 | 44 | 187.80 | 1.17% | 5.00% |
≥ 95 | 23 | 407.41 | 0.21% | 3.70% |
Total | 29,938 | 68,056.53 | 7.65% | 17.38% |